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Abstract.
Background: Early prognosis of high-risk older adults for amnestic mild cognitive impairment (aMCI), using noninvasive
and sensitive neuromarkers, is key for early prevention of Alzheimer’s disease. We have developed individualized measures in
electrophysiological brain signals during working memory that distinguish patients with aMCI from age-matched cognitively
intact older individuals.
Objective: Here we test longitudinally the prognosis of the baseline neuromarkers for aMCI risk. We hypothesized that the
older individuals diagnosed with incident aMCI already have aMCI-like brain signatures years before diagnosis.
Methods: Electroencephalogram (EEG) and memory performance were recorded during a working memory task at baseline.
The individualized baseline neuromarkers, annual cognitive status, and longitudinal changes in memory recall scores up to
10 years were analyzed.
Results: Seven of the 19 cognitively normal older adults were diagnosed with incident aMCI for a median 5.2 years later. The
seven converters’ frontal brainwaves were statistically identical to those patients with diagnosed aMCI (n = 14) at baseline.
Importantly, the converters’ baseline memory-related brainwaves (reduced mean frontal responses to memory targets) were
significantly different from those who remained normal. Furthermore, differentiation pattern of left frontal memory-related
responses (targets versus nontargets) was associated with an increased risk hazard of aMCI (HR = 1.47, 95% CI 1.03, 2.08).
∗Correspondence to: Yang Jiang, PhD, Associate Professor,
Director, Aging, Brain, and Cognition Laboratory, Department of
Behavioral Science, University of Kentucky College of Medicine,
113 Medical Behavioral Science Building, 1100 Veterans Drive,
Lexington, KY 40536-0086, USA. Tel.: +1 859 257 2122; E-mail:
yjiang@uky.edu.
ISSN 1387-2877/21/$35.00 © 2021 – The authors. Published by IOS Press. This is an Open Access article distributed under
the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC 4.0).
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Conclusion: The memory-related neuromarkers detect MCI-like brain signatures about five years before diagnosis. The
individualized frontal neuromarkers index increased MCI risk at baseline. These noninvasive neuromarkers during our
Bluegrass memory task have great potential to be used repeatedly for individualized prognosis of MCI risk and progression
before clinical diagnosis.
Keywords: Amnestic mild cognitive impairment, cognitive ERP, delayed match-to-sample, dementia risk, EEG, memory-
related potentials, working memory
INTRODUCTION
Progression of Alzheimer’s disease (AD) and re-
lated dementia (ADRD), which involves synaptic,
metabolic, and structural changes during brain aging,
slowly lead to loss of cognition. Among the most
common early symptoms of dementia are deficits in
working memory and executive dysfunction as well
as episodic memory deficits [1]. Working memory
is the capacity to hold active information in one’s
memory for immediate manipulation [2]. Currently,
there are no effective disease-modifying treatments
for clinical dementia, thus prevention is critical.
By detecting amnestic mild cognitive impairment
(aMCI), an early stage of dementia, clinical onset can
be delayed through modification of lifestyle factors
[3] and early interventions. Not all persons ever diag-
nosed with aMCI will necessarily develop clinical
ADRD [4]. Recent results from the SPRINT-MIND
trial suggest that intensive systolic blood pressure
control in older adults with hypertension may delay
progression of MCI to dementia [5].
Substantial progress has been made in detecting
early pathological changes in living persons by using
AD biomarkers with positron emission tomography
(PET) imaging, A in the cerebrospinal fluid (CSF)
or plasma [6], and CSF and PET biomarkers for
AD diagnosis [7]. However, many cognitively intact
older adults perceive the procedures as invasive and
expensive, and instead prefer noninvasive and cheap
screening tools for assessing their risk of cognitive
decline. If there is a risk for cognitive deficits, acc-
essing sophisticated neuroimaging facilities for eval-
uation of dementia would be required. But in most
cases, electrophysiological signals measured by ele-
ctroencephalography (EEG), are noninvasive, afford-
able, and more suitable to healthy and cognitively
intact older adults. EEG is a tool that measures the
summations of neural postsynaptic potentials at the
scalp and has been used for several decades. What
is new here is applying memory-related potentials
(averaged EEG signals during memory retrieval) sen-
sitive to early synaptic changes in the brain to predict
cognitive impairment at an individual level. Using
a working memory task (modified delayed match-
to-sample) during functional neuroimaging [8], we
reported that memory-related cortical connectivity
changes correlate with increased CSF AD biomark-
ers A deposits and pTau in the brain. EEG network
oscillations of brain activity have also been shown to
act as a sensitive tool for evaluating neural dynamics
of the mouse brain [9].
Averaged EEG signals, known as event-related
potentials (ERPs), associated with cognitive events
are a well-studied approach for indexing brain res-
ponses associated with memory and cognition. Speci-
fically, ERPs measure synchronized synaptic neural
activity associated with a cognitive event (e.g., mem-
ory retrieval). The science of using cognitive ERPs
as predictive biomarkers for ADRD remains in its
infancy; however, findings show that ERP signals dur-
ing cognitive tasks, either in amplitude or in latency,
are altered in patients with MCI and ADRD [10–14].
Previous studies show that memory task-induced
responses in a network of brain regions such as
the hippocampus, posterior cingulate cortex (PCC),
and medial prefrontal cortex [15] are vulnerable to
cognitive aging, preclinical AD [8], aMCI, and AD
[12]. More importantly, these memory-induced brain
responses also correlate with CSF A42 (pg/ml) and
pTau181 (pg/ml) in normal older adults [8]. Further-
more, Li et al. (2017) have identified brainwave pat-
terns that are distinguishable among normal controls,
aMCI, and AD brains using unified ERP criteria in
conjunction with a short-term memory task (Fig. 2A)
[12]. Using a delayed match-to-sample task (Fig. 1)
in this study, we have reported left-frontal memory-
related potentials as a ‘neuromarker’ for aMCI.
Given these findings, the goal of the present study
was to test whether individuals’ frontal brainwaves
during a visual object working memory task could
predict future cognitive status, i.e., incident diag-
noses of aMCI. Our central hypothesis was that ind-
ividuals who converted to MCI years later would
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Fig. 1. The Bluegrass memory paradigm is a modified delayed match-to-sample working memory task lasting approximately 18 minutes for
each participant. In each memory trial (16 seconds), a participant was instructed to remember a presented sample target image (for 3 seconds)
and then indicate whether each subsequent image (with a jittered delay 1.1–1.4 seconds) was a Match to the sample Target or a Nonmatch
(Nontarget) by pressing a corresponding button (A or L key). EEG (64-channel NeuroScan) and memory performance were recorded. A new
sample image was used in each trial. Individual images (either target or non-target) were tested two or three times per trial. Note on images:
Sample Target = Target = Match; Non-match = Nontarget = Distractor during memory.
Fig. 2. A. F753 is averaged left frontal memory-related potentials of F3, F5, and F7. The blue circle indicates location of left frontal sites from
left to right F7, F5, and F3. Baseline memory-related potentials and topographical maps in Normal Cognition (NC) and patients with MCI
groups (adapted from [12]). The yellow highlight indicates the differences (diff) of memory-related potentials (Target Match – Nontargets
Nonmatch).
have MCI-like memory-related ERP signatures at
baseline compared to individuals who remained cog-
nitively intact. We tested three likely predictors of
cognitive impairment: 1) Reduced frontal responses
to retrieval of memory-target (Target Match); 2)
Enhanced frontal signals of distractors, i.e., memory-
nontargets (Nontarget; Nonmatch), which reflect
decline in frontal ability to filter task-irrelevant items;
and 3) Cognitive impairment due to reduced differen-
tiation of neural mechanisms associated with memory
targets and distractors (i.e., differences of memory-
related brainwaves).
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Fig. 2. B. Distribution of memory-related potentials by groups: Normal cognition, incident MCI who were normal at baseline, and baseline
MCI. Symbols (e.g.,+) are outlier individuals. The right most panel is not direct measures but combined indicators: F753 = mean of measures
of F7, F5, and F3; diff = Target match – nonmatch, the more positive value of the diff, the more similar to younger and healthy direction.
The negative diff values are MCI-like. The middle group (red) were normal at baseline, but diff values are MCI-like already.
MATERIALS AND METHODS
Participants and evaluations
Thirty-four community-dwelling older adults were
recruited from the University of Kentucky Alzhei-
mer’s Disease Center (UK-ADC) research volunteer
cohort. Annual neuropsychological and clinical dia-
gnostic procedures at the UK-ADC have been
described elsewhere [17]. Each year, an older in-
dividual received several memory-related neuro-
psychological tests including the California Verbal
Learning Test (CVLT) [18]. To note, aMCI is consid-
ered MCI due to AD pathologies and was assigned
in accordance with the national standards [19]. Par-
ticipants were evaluated with an annual detailed
cognitive and clinical assessment by UK-ADC per-
sonnel, followed by a multidisciplinary consensus
conference to determine their clinical diagnosis: 1)
remains normal, no change; 2) conversion to MCI
diagnosis by the examining physician is based on cri-
teria of history and Clinical Dementia Rating Scale
(CDR) score. In cases where memory was the dom-
inant component of cognitive decline, the objective
decline in memory test score 1.5 standard deviation
below cutoff was subclassified as amnestic type MCI
(aMCI); (3) criteria-based diagnosis of Alzheimer’s
disease (AD) or other dementia [19].
In addition to the annual neuropsychological test-
ing and clinical assessments at the UK-ADC, at
baseline each participant underwent an EEG record-
ing during the memory task in the Aging, Brain, and
Cognition Laboratory in the Department of Behav-
ioral Science, UK College of Medicine on a separate
day [12]. Note that these cognitively intact normal
older adults did not receive a diagnosis of Alzheimer’s
neuropathology or disease based on standard CSF
or PET biomarkers at baseline. One older individ-
ual who was MCI at age 67 at baseline did not show
AD pathology in their autopsy at death at the age of
77. We have removed this individual from the aMCI
group in this analysis.
All research activity was approved by the Univer-
sity of Kentucky Institutional Review Board and all
participants provided written informed consent.
The task and memory-related potentials
The Bluegrass working memory task (Fig. 1) is
a modified delayed match-to-sample task. For each
memory trial, a participant holds the sample tar-
get image in his/her working memory and indicates
Y. Jiang et al. / Prognostic Neuromarkers for Cognitive Decline 535
whether each subsequent image is the sample target
(Target match or Non-match) by pressing a button.
EEG and memory performance, i.e., accuracy (%)
and reaction times (milliseconds) were recorded dur-
ing the visual working memory task. The Snodgrass
and Vanderwart images are presented using E-prime
(Psychology Software Tools, US).
EEG recording and EEG preprocessing
Scalp electrical signals were recorded using a
64-channel NeuroScan cap while the participants
were engaged in a modified delayed match-to-sample
task. These electrodes were referenced to a midline
electrode during recording and re-referenced to the
average of the right and left mastoid potentials offline.
Two additional channels were used for monitoring
horizontal and vertical eye movements. Impedance
was maintained below 5 k. EEG data were filtered
using a band-pass of 0.05–40 Hz and sampled at a
rate of 500 Hz. Each averaging epoch lasted 1,100
milliseconds, including 100 milliseconds prior to
stimulus onset.
A regression algorithm implemented with Neu-
roScan software (Compumedics, Australia) was used
to reduce the influence of eye blink artifact on the
EEG recording. More details of EEG recording and
analysis have been previously described [12]. Of the
34 participants who underwent EEG, one did not
have data available for the memory task and was
excluded, leaving 33 participants in the current study.
Here we examined the predictivity of three different
left frontal sites of F7, F5, and F3, where significant
brainwave differences between CN and MCI patients
were reported during the working memory task [12].
Statistical analysis
For participants with initially intact cognition, we
assessed the association between ERPs and measures
of both short-delayed recall and long-delayed recall.
We used Pearson correlations based on the CVLT-II
[18] standardized scores (i.e., age, sex, and education
specific Z scores) for short- and long-delayed recall
obtained at the time of the EEG and at last follow-up.
Additionally, we used proportional hazards regres-
sion, with age as the time scale and no additional
covariates, to estimate hazards of aMCI. Participants
who were not diagnosed with incident aMCI were
censored at their last UK-ADC assessment.
While 0.05 was used as the nominal significance
level, we interpreted our results cautiously due to the
small sample and number of comparisons made. Our
primary focus was the pattern of results. All statistical
analyses were performed in SAS 9.4®.
Analysis of covariance (ANCOVA) was used to
assess mean group event-related potentials (ERPs)
between groups using Prism 7 (http://www.graphpad.
com). Adjustment covariates were age at the EEG
assessment and years of education. Additionally,
memory-related potentials were further tested using
a nonparametric test (The Kruskal-Wallis test) using
SPSS Statistics 26.
RESULTS
At baseline EEG, 14 carried a diagnosis of aMCI
and 19 had normal cognition (NC) at the EEG
(Table 1). After a median follow-up of 5.2 years
(range 2.2–7.9 years), 7 out of 19 baseline NC had
been diagnosed with incident aMCI.
We rechecked each incident aMCI individual’s
CVLT and diagnosis data at baseline when they were
normal. Despite their low scores on the CVLT recall
tests, these 7 participants received a consensus diag-
nosis of normal cognition at the time of the testing and
for multiple years afterward (e.g., approx. 8 years, 7
years, 4 years, 3 years, 4 years, 9 years, and 4 years).
These CVLT scores indicate that they already had
memory-related neural impairment, but overt clinical
symptoms did not appear until years later.
Left frontal memory-related indicators as
predictors
We previously reported a frontal memory-related
brainwave signature: enhanced left frontal positive-
Table 1




(n = 12) (n = 7) (n = 14)
Age (y) 74.6 ± 4.7 76.9 ± 4.7 76.4 ± 9.9
Sex (n, % female) 8 (66.7) 5 (71.4) 4 (28.6)
Education (y) 16.9 ± 2.6 16.0 ± 3.1 16.8 ± 2.1
MMSE (max = 30) 29.4 ± 0.7 28.6 ± 1.0 27.6 ± 2.3
CVLT-II Short Delay 11.8 ± 3.4 7.7 ± 3.9 7.3 ± 2.7
Free Recall (max = 16)
CVLT-II Long Delay 12.7 ± 2.6 8.0 ± 3.5 6.3 ± 4.1
Free Recall (max = 16)
MCI, mild cognitive impairment; MMSE, Mini-Mental State
Examination; max, maximum; CVLT-II, California Verbal Learn-
ing Test-II.
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Table 2
Mean (±SEM) Adjusted Left Frontal Memory-Related Potentials
Left Frontal Normal Incident Baseline
Sites Predictor Cognition MCI MCI
(n = 12) (n = 7) (n = 14)
F7 target 5.27 ± 0.81 2.74 ± 1.06 1.46 ± 0.77∗
F5 target 5.67 ± 0.88 3.42 ± 1.16 1.99 ± 0.84∗
F3 target 6.25 ± 0.95 4.19 ± 1.25 2.62 ± 0.91∗
F7 nontarget 4.68 ± 0.92 4.50 ± 1.21 3.68 ± 0.88
F5 nontarget 5.01 ± 0.95 5.32 ± 1.24 3.87 ± 0.90
F3 nontarget 5.51 ± 0.98 6.10 ± 0.93 4.04 ± 0.93
F753 diff 0.66 ± 0.58 −1.86 ± 0.75∗ −1.84 ± 0.56∗
F7 diff 0.59 ± 0.63 −1.75 ± 0.83∗ −2.22 ± 0.60∗
F5 diff 0.65 ± 0.60 −1.90 ± 0.79∗ −1.88 ± 0.57∗
F3 diff 0.74 ± 0.59 −1.91 ± 0.79∗ −1.42 ± 0.57∗
∗Indicates significantly different from the least squares means
(SEM) of Normal Cognition, adjusted for age at assessment and
education. The diff variables are created index diff = target – non-
target; F753 is not direct measurement but averaged signals from
three left frontal sites, i.e., F7, F5, and F3 (see Fig. 2A).
going responses were associated with non-matching
relative to matching targets during working mem-
ory in aMCI, but not in normal cognition [12]. Here,
we examined each individual’s characteristics asso-
ciated with multiple measures of frontal ERP (F7,
F5, and F3; Fig. 2A), as well as a combined aver-
aged left-frontal measure, F753 (averaged signals
of three left frontal sites), of differentiation (Target
match - Non match). Based on our previous work
[12], ANOVA revealed significant adjusted mean dif-
ferences in cognitive ERP between those who had
aMCI at baseline and those who remained normal
(Table 2).
In searching for effective neuromarkers predic-
tors, we compared unadjusted multiple left frontal
memory-related indicators (Fig. 2A) by diagnosis
groups which are presented in Fig. 2B.
In addition to significant mean differences
between those who remained cognitively normal ver-
sus those who developed aMCI, we also observed that
memory-target responses differed. Differentiation
of memory-related brainwaves produced remark-
ably consistent hazard ratios (HR) for incident MCI
(Table 3; HR range 0.58–0.77), with significant asso-
ciations for F753 diff, F7 diff, and F3 diff. Also
striking was the consistent estimate of HRs around
1.00 for non-target ERPs.
Frontal memory-related potentials were weakly to
strongly correlated with both CVLT-II short- and
long-delayed recall standardized scores obtained
proximal to the EEG. Scores were significantly ass-
ociated with multiple measures of Diff and Target, but
not significantly associated with Nontarget (Table 3).
Interestingly, ERPs were more strongly associated
with long-delayed recall at the last follow-up than
at the EEG for all measures (Table 3), with sig-
nificant associations with Target and Diff, but not
Nontarget. No ERP measures were significantly asso-
ciated with short-delay recall at last follow-up, and all
correlations were attenuated relative to the CVLT-II
proximal to the EEG.
Individuals’ left frontal memory-related
potentials
We further tested differences between memory-
related potentials using the two frontal indicators
(F753, and F5) in three types of individuals (Fig. 3).
One-way ANOVA showed that the three types of
Table 3
Pearson Correlation of Left Frontal Memory-related Neuromarkers and CVLT-II Delayed Recall
at Baseline and Last Follow-Up (mean follow-up interval = 8.1 years)
Left Frontal At Baseline At Last
Predictor Follow-Up
Short-delay Long-delay Short-delay Long-delay
Recall Recall Recall Recall
F7 target 0.56 (0.01) 0.43 (0.07) 0.44 (0.10) 0.64 (0.01)
F5 target 0.64 (0.003) 0.51 (0.03) 0.43 (0.11) 0.62 (0.01)
F3 target 0.61 (0.0005) 0.43 (0.07) 0.33 (0.23) 0.57 (0.03)
F7 nontarget 0.27 (0.27) 0.16 (0.33) 0.19 (0.50) 0.25 (0.37)
F5 nontarget 0.33 (0.17) 0.24 (0.33) 0.23 (0.42) 0.30 (0.29)
F3 nontarget 0.33 (0.17) 0.18 (0.47) 0.17 (0.54) 0.30 (0.28)
F753 diff 0.39 (0.16) 0.31 (0.20) 0.33 (0.23) 0.53 (0.04)
F7 diff 0.39 (0.16) 0.32 (0.19) 0.36 (0.19) 0.55 (0.03)
F5 diff 0.33 (0.17) 0.29 (0.23) 0.34 (0.22) 0.54 (0.04)
F3 diff 0.34 (0.15) 0.32 (0.18) 0.29 (0.29) 0.49 (0.06)
All participants included in this analysis were cognitively intact at the time of the baseline EEG (N = 19). Results
presented are r (p value). Values in Bold are significant. The diff variable are created index diff = target – nontarget;
F753 is averaged signals of three left frontal sites, i.e., F7, F5, and F3 (see Fig. 2A).
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Fig. 3. The cognitively older healthy individuals at baseline (pink) who showed the MCI-like brainwaves at baseline converted to aMCI
after 5.2 years. Baseline negative value signals risk for MCI in a normal older adult. A. Left frontal difference waves of memory target and
nontargets (F753) are statistically significant between individual converters from non-converters (remain cognitively normal after averaged
10 years). Yet, similar memory-related ERP indexes between converters and baseline MCIs. Baseline negative value signals risk for MCI in
a normal older adult. B. The left frontal (F5 site) responses to retrieval of memory-target in three types of individuals.
individuals were different [F753, F(2, 32) = 6.802,
p < 0.005; F5 F(2, 32) = 5.890, p < 0.01]. The planed
comparisons between MCI converters versus those
who remained normal were the most interesting.
We found significant differences between convert-
ers’ and non-converters’ ERPs at baseline (Fig. 3A).
The F753 difference waveforms of memory negative
value indicates MCI-like high risk pattern (reduced
target-related frontal responses). Older individuals
who later converted to MCI showed MCI-like pat-
terns at baseline compared to those who remained
normal (F753 diff, p < 0.01; F5 p < 0.01).
The incident MCI converters’ patterns were not
significantly different from those seen in individuals
with MCI at baseline (p > 0.10), which means that
the cognitively normal individuals who converted to
MCI later already had the brainwave patterns similar
to those of MCI patients at baseline. Interestingly, the
F753 diff values, of almost all individuals with MCI
at baseline and later MCI converters, were negative
(below zero dash line in Fig. 3A).
Nonparametric analysis
Given the small sample of the converters, we fur-
ther validate the results using nonparametric analysis.
The Kruskal-Wallis test, a nonparametric (distribu-
tion free) test was conducted that provided evidence
of a significant difference (p < 0.05) in at least one pair
of groups in F753. Dunn’s pairwise tests were used
Table 4
Left Frontal Cox Proportional Hazards Model Results for Hazard
of MCI (Age as Timescale)
Left Frontal 1-unit Increase 1-unit Decrease
Predictor in Predictor in Predictor
F7 target 0.65 (0.42, 1.01) 1.54 (0.99, 2.38)
F5 target 0.58 (0.33, 1.01) 1.72 (0.99, 3.03)
F3 target 0.67 (0.44, 1.01) 1.49 (0.99, 2.27)
F7 nontarget 1.02 (0.80, 1.31) 0.98 (0.76, 1.25)
F5 nontarget 1.04 (0.83, 1.29) 0.96 (0.78, 1.20)
F3 nontarget 1.03 (0.82, 1.28) 0.97 (0.78, 1.22)
F753 diff 0.68 (0.48, 0.97) 1.47 (1.03, 2.08)
F7 diff 0.65 (0.45, 0.95) 1.54 (1.05, 2.22)
F5 diff 0.77 (0.57, 1.05) 1.30 (0.95, 1.75)
F3 diff 0.70 (0.50, 0.98) 1.43 (1.02, 2.00)
Results are Hazard Ratio with 95% Confidence Interval. Bolded
results are statistically significant at the 0.05 level. The diff vari-
able are created index diff = target – nontarget; F753 is averaged
signals of three left frontal sites, i.e., F7, F5, and F3.
for analyzing the three pairs of groups. There was a
significant difference (p = 0.004, adjusted using the
Bonferroni correction) between the baseline aMCI
group and non-converters. There was no significant
difference (adjusted p = 1.0) between the baseline
aMCI group and converters. The difference between
non-converts and converters did not reach the signif-
icance level (adjusted p = 0.102).
The same tests were used to analyze data in
F5 Target, which showed similar results. A signifi-
cant difference (p < 0.05) was found between baseline
aMCI group and non-converts (adjusted p = 0.008),
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whereas no significant difference was found in the
other two pairs of groups.
Hazard ratio analysis on risk of MCI
We also observed that all ERP measures of
memory-target response (Target) and differentiation
of memory-related brainwaves (Diff) produced haz-
ard ratios (HR) for incident aMCI in the range
0.58–0.77 (Table 4), with statistically significant
associations for F753 diff, F7 diff, and F3 diff. Also
striking was the consistent estimate of HRs around
1.00 for nontarget ERPs (Nontarget). Thus, the best
predictors for aMCI risk are the left frontal difference
brainwaves.
DISCUSSION
Summary of key results
We previously reported that, at the baseline EEG
assessment, the group means of left frontal visual
memory-related potentials were different between
participants with normal cognition and those with
aMCI in carefully evaluated older adults [12]. We
now show that cognitive neuromarkers among cog-
nitively normal individuals who converted to aMCI
during follow-up showed significantly different pat-
terns of left frontal memory-related potentials com-
pared to those who remained normal. In addition,
we report that reduced left frontal memory-target
related signals at baseline predicts later conversion
to aMCI.
Our results indicate that brainwaves obtained dur-
ing a specific working memory retrieval demonstrate
an aMCI-like pattern in some cognitively normal
older adults at an average of five years before aMCI
conversion. These noninvasive and easy EEG neuro-
markers allow repeated measures over time and may
prove to be a useful prognostic measure of aMCI risk.
Additionally, wireless, wearable, noninvasive, and
cloud-based EEG measurements hold great promise
in community clinics and future telehealth applica-
tions.
Our results support the central hypothesis that the
aMCI converters’ memory-related brainwave patte-
rns are similar to patients with aMCI even at the pre-
clinical stage. This indicates that alteration of
brainwaves underserving memory is present before
clinical symptoms or definitive changes in cognitive
tests. Since the memory-related neuromarkers were
brain signals detected at the left frontal electrode
sites, frontal responses at baseline in normal aged
persons may be a “canary in the coal mine” indi-
cating the presence of underlying changes affecting
a particularly sensitive dynamic memory network.
Future memory declines in these individuals would
represent further degradation of other brain networks
by advancing pathology. Among the three measures
from three locations, the prediction using differences
of memory targets vs nontargets separated individu-
als who remained cognitively intact versus those who
become incidental MCIs or MCI at baseline (Fig. 2B).
The frontal memory target-related potentials alone
also showed some degrees of differences between
converters and nonconverters.
The current results indicate that individualized
neuromarkers based on brainwave patterns at pre-
aMCI are predictive of aMCI conversion about 5
years later. The question remains, what exactly do
these the memory-related neuromarkers measure?
Predicting MCI and risk for dementia using ele-
ctrophysiological signals (reflecting synaptic functi-
ons) in the brain have been gaining momentum in
recent decade [16]. The left frontal EEG during the
working memory task is likely brain activity from
known working memory network, which is also seen
in the left frontal regions during the same task using
functional magnetic resonance imaging (fMRI) [8,
20]. This memory-related brainwave pattern is possi-
bly localized at left frontal BA 46 and BA 10, the
classic working memory and executive control reg-
ions of the brain [21]. Interestingly, using language-
based memory tasks, the frontal regions also show
discriminative patterns between NC and MCI [10,
12–14]. Prediction of AD using the current left
frontal memory-related markers is consistent with a
previously reported successful prediction using an
incidental repetition learning paradigm [14]. Seven
elderly persons with normal cognition at the time of
EEG recordings who showed subsequent cognitive
decline or AD pathology at autopsy (n = 5, Braak
stage = 2.8), were compared to 13 normal elderly who
remained cognitively normal after ten years. The
P600 congruous word repetition ERP effects (New
minus Old congruous words) were significantly
larger than those in Pre-AD. The prediction rate was
84% in identifying conversion to MCI or AD [14].
One difference between our visual memory task and
others is that memory-related potential measures
memory retrieval of explicit memory target and
nontarget, while the repetition priming used by
Olichney’s group measures a more implicit memory
process.
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Nature of the left frontal visual memory-related
neuromarkers
The modified version of the delayed match-to-
sample task has been used in monkey physiology and
human neuroimaging studies on working memory.
Our previous study has linked brain activity measured
by functional MRI during this memory paradigm to
distinct cortical regions known to be vulnerable to
cognitive aging and impairment caused by preclini-
cal AD [8, 22]. We reported that the left prefrontal
memory-related potentials during the task are signif-
icantly different between NC, aMCI, and AD groups
[12].
Here we tested three hypotheses on how the left
frontal memory-related brainwaves predict future
cognitive impairment: 1) Reduced memory-target
(Target) related frontal responses; 2) Enhanced
frontal signals of distractors (i.e., nontar-
get/nonmatch), which reflect decline in frontal
ability to filter task-irrelevant items and correlate
with faster memory decline; and 3) Cognitive
impairment due to changes in both neural mecha-
nisms reducing differentiation of memory-related
brainwaves (diff = Target - Nontarget).
Our results revealed that the different brainwaves
between memory Target and Nontargets in two left
frontal electrodes (F7 or F3 in Table 4) or aver-
aged from three left frontal sites (F753) are the best
predictor (#3). Reduced brain responses to mem-
ory targets (#1) also predicted well. However, it
was somewhat surprising that increased distraction
(#2) typically seen in cognitive aging did not predict
well. Our results suggest that the enhanced prefrontal
response to memory targets (match) in the absence
of stimuli during a delay period is the neuromarker
of good maintenance during working memory. The
neural responses reported in noninvasive human neu-
roimaging studies [19–22] are consistent with those
obtained using invasive techniques in animals [24].
During target matches both show enhanced neural
responses in the left frontal cortex and, to a lesser
degree, in the temporal cortex. Elevated left frontal
brain responses have also been reported by groups
using fMRI during contextual memory retrieval
tasks [25].
Importantly, our visual memory-related left frontal
neuromarker is individual-based and noninvasive.
Thus, the neuromarker offers great promise to
become a dynamic indicator for aMCI that can be
repeatedly used even within a short time period before
explicit changes in memory performance or structural
brain changes are seen. In addition, it is also a useful
test that can be used across culture and languages.
The previous work with participants from UK-
ADC longitudinal aging cohort identified increased
loss of projections from the entorhinal cortex to the
frontal and parietal regions with progression of AD
[8]. This is important because aMCI is often a pre-
cursor to dementia [23, 27], and expresses different
neural network function during resting-state [28], and
during memory task [12] in our preclinical aging
cohort. These neural afferents have been described
as helping maintain working memory through short-
term synaptic facilitation in animal models [29]. The
Bluegrass memory task activates an enlarging net-
work of brain regions as task difficulty increases.
Greater network activation represents cognitive com-
pensation related to the need to hold memory target
online during working memory retrieval. The current
report on altered brainwave patterns in normal per-
sons who later develop MCI is consistent with other
reports of EEG brain network changes in AD [30].
In summary, we show that a modified delayed
match-to-sample task produces neuromarkers in nor-
mal persons that predict MCI up to 10 years before
the conversion. A limitation of the current study is
that the relatively small sample size does not allow a
precise estimation of the associations we described.
In addition, the older participants were selected in
a non-random manner from the available population
(normal subjects were simply asked if they would
like to participate in this study as they appeared for
their annual UK-ADC assessment). Thus, the partic-
ipants were taken from a pool of research volunteers
that are generally healthy and highly educated, which
is not representative of the general US population.
Nonetheless, this study provides a foundation for
future validation in a large-scale longitudinal study.
To meet the urgent need for developing new non-
invasive and affordable biomarkers to predict aMCI
at the preclinical stage, we demonstrated that neu-
romarkers from the Bluegrass memory paradigm are
more sensitive to neural and cognitive changes than
conventional neuropsychological tests. With their
large estimated effect size, our testing results sug-
gest that individualized memory-related brainwave
patterns in normal older adults predict aMCI an aver-
age of five years before conversion. This is significant
because aMCI is strongly associated with the later
development of AD. The noninvasive neuromarkers
have great potential to be used repeatedly and lon-
gitudinally as an individualized risk assessment for
prediction of MCI before clinical diagnosis.
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Conclusions
Until now, non-invasive ‘neuromarkers’ predict-
ing and monitoring risk for MCI have been lacking.
EEG rhythms during resting-state and sleep are used
as neuromarkers for clinical trials in AD. We fol-
lowed the normal older adults over an average of eight
years; here we report that memory-related potentials
at baseline could serve as a useful marker to pre-
dict MCI about five years before MCI diagnosis. We
reveal longitudinal validation that left frontal elec-
trophysiological measures during working memory
are effective in identifying MCI risk in cognitively
normal older adults, which is consistent with several
decades of neural evidence on monkey single-cell
physiology acquired through invasive microelec-
trodes, and functional neuroimaging methods. Our
findings provide new evidence that EEG during work-
ing memory shows great promise as a non-invasive
and reliable predictor of cognitive decline.
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